TUG1 and glioma: Moreover, this study used both the activators and inhibitors of the mTOR/S6K pathway and confirmed that TUG1 controls HCC growth via the mTOR/S6K axis.123 CRNDE is one of the highly overexpressed lncRNA in patients with glioma and glioma cell lines.